Latest From Biotech Now

Coalition Offers a Remedy for Stagnated Clinical Trials

lab_tech

Promising new clinical trial data offers fresh hope for the families of Alzheimer’s patients.  A new medication seems to be slowing the disease’s progress, limiting the cognitive decline that characterizes this “long goodbye.” Wouldn’t it be wonderful for patients suffering other diseases to have equally encouraging prospects? But many do not. Part of the problem lies with clinical trials.  For a new medication to receive FDA approval, it must undergo comprehensive testing on actual patients.  Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

What to Watch: Emperor of All Maladies; Killing Cancer

Annie Cavanagh. Wellcome Images

Cancer is a disease which affects almost 1.7 million people each year in America, and is the fastest growing disease on Earth. Two television shows this week explore the history of the complex illness, as well as recent treatment advances that are providing new hope for many patients. The first is a television adaptation of Siddhartha Mukherjee’s The Emperor of All Maladies: A Biography of Cancer, which won the Pulitzer Prize for Nonfiction. The TV Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

2015: A Promising Year for Biotech Jobs

BIO_Career_Fair

If you’re in the biotech sector and are looking for a new career, you’re in luck: according to a recent survey by BioSpace, 70% of respondents believe new jobs will be on the horizon this year. The majority of respondents say that small firms will lead the hiring rush. The poll was split over where most hiring would occur, with 39% believing it would go to research and development jobs, and 39% believing it would Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Jim Greenwood on the Road: Opening Bell at NASDAQ

Jim Ringing Nasdaq Bell

Jim Greenwood, BIO’s President and CEO, rang the opening bell this morning at the NASDAQ MarketSite in New York. Joining him on the stage were a number of BIO members and affiliates, including NewYorkBIO Executive Director Nathan Tinker, Pennsylvania Bio President Christopher Molineaux, DelawareBio Chairman Christopher Yochim, and BioNJ President Debbie Hart. Several BIO member companies were also represented, including Acorda Therapeutics President and CEO Ron Cohen, who also serves as Vice Chair of BIO’s Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , ,

“The Weight of Evidence Strongly Suggests that Glyphosate Does Not Cause Cancer.”

GMO-Answers1 copy

In recent news, the International Agency for Research on Cancer (IARC) announced that it has labeled the widely used herbicide glyphosate as “probably carcinogenic” to humans in its upcoming review of the product.  Unfortunately, since IARC is an agency of the World Health Organization, the report has been seen as having some credibility. However the report is not as accurate as it appears.  GMO Answers expert Dr. Michael Greenberg explains his post flaws within IARC’s findings: Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,